Variables | Intervention group | Within-group p-value | No Intervention group | Within-group p-value | Between-group p-value |
---|---|---|---|---|---|
 | (n = 50) |  | (n = 50) |  |  |
Healthy Lifestyle Index, mean (SD)a | |||||
 Baseline | 2.1 (0.99) |  | 2.4 (1.03) |  |  |
 Final | 2.3 (1.04) | 0.43 | 2.2 (0.89) | 0.35 |  |
 Change | 0.16 (0.68) |  | −0.18 (0.75) |  | 0.02* |
Healthy Lifestyle Index, median (IQR)a | |||||
 Baseline | 2 (1, 3) |  | 2 (2, 3) |  |  |
 Final | 2 (2, 3) | 0.54 | 2 (2, 3) | 0.48 |  |
 Change | 0 (0, 0) |  | 0 (−1, 0) |  | 0.01* |
Anti-hypertensive medication adherence | |||||
PDC (any medication class)b,c, % | 95.27 | Â | 83.78 | Â | <0.01* |
PDC (all medication classes)b,c, % | 92.05 | Â | 84.47 | Â | 0.03* |
Mean Systolic blood pressure (> = 140 mmHg), mean (SD) | |||||
 Baseline | 158.0 (11.9) | <0.001* | 160.66 (15.7) | <0.001* |  |
 Finald | 142.79 (13.3) | 140.17 (12.9) |  | ||
 Adjusted change mm Hg, mean (95%CI)e | −17.58 (−24.06 to −11.11) | −18.99 (−25.88 to −12.09) | 0.58 | ||
Mean Diastolic blood pressure (> = 90 mmHg), mean (SD) | |||||
 Baseline | 94.6 (5.7) | <0.001* | 96.86 (11.5) | <0.001* |  |
 Finald | 80.82 (11.7) | 86.86 (10.5) |  | ||
 Adjusted change mm Hg, mean (95%CI)e | −15.6 (−20.85 to −10.35) | −12.93 (−18.48 to −7.37) | 0.19 |